DPP4 and cardiovascular disorder: Despite substantial evidence from extensive cardiovascular outcome trials supporting the cardiovascular safety of dipeptidyl peptidase-4 (DPP-4) inhibitors, no benefit in preventing cardiovascular disease has been observed.